Showing 1 - 5 results of 5 for search 'Seyed Reza Mousavi (13223324)', זמן שאילתה: 0.01s Refine Results
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. מאת Seyed Reza Mousavi (13223324)

    יצא לאור 2025
    הוספה למועדפים
    שמור ב:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. מאת Seyed Reza Mousavi (13223324)

    יצא לאור 2025
    הוספה למועדפים
    שמור ב:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. מאת Seyed Reza Mousavi (13223324)

    יצא לאור 2025
    הוספה למועדפים
    שמור ב:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. מאת Seyed Reza Mousavi (13223324)

    יצא לאור 2025
    הוספה למועדפים
    שמור ב:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. מאת Seyed Reza Mousavi (13223324)

    יצא לאור 2025
    הוספה למועדפים
    שמור ב:

כלי חיפוש: